New RSV vaccine called Arexy approved for people aged 60 and older
Health Canada has authorized the first RSV vaccine for people aged 60 and older.
Doctors have been calling for the vaccine for this group, which is at a higher risk of becoming severely ill from the virus.
Drugmaker GSK says during clinical trials, the drug was 82 percent effective at lowering respiratory tract disease caused by RSV.
In Canada, RSV season usually starts in the fall, and ends in the spring.

Welland adopts 2026 Budget with 4.01% increase
Port Colborne Man Charged with Child Luring
Social Assistance Recipients Receiving Help
Man Faces Multiple Impaired Driving Charges
Police Looking for Stolen Wine
Airport Working to End Sexual Exploitation
Ontario Student Learning Under Review
Senior Seriously Hurt in Parking Lot